- Home
- SWZ vs PYXS Comparison
SWZ vs PYXS Comparison
Compare SWZ & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- PYXS
- Stock Information
- Founded
- SWZ 1986
- PYXS 2018
- Country
- SWZ United States
- PYXS United States
- Employees
- SWZ N/A
- PYXS N/A
- Industry
- SWZ Finance Companies
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- SWZ Finance
- PYXS Health Care
- Exchange
- SWZ Nasdaq
- PYXS Nasdaq
- Market Cap
- SWZ 98.3M
- PYXS 101.1M
- IPO Year
- SWZ N/A
- PYXS 2021
- Fundamental
- Price
- SWZ $8.56
- PYXS $1.53
- Analyst Decision
- SWZ
- PYXS Strong Buy
- Analyst Count
- SWZ 0
- PYXS 8
- Target Price
- SWZ N/A
- PYXS $9.43
- AVG Volume (30 Days)
- SWZ 14.2K
- PYXS 784.5K
- Earning Date
- SWZ 01-01-0001
- PYXS 11-12-2024
- Dividend Yield
- SWZ 6.59%
- PYXS N/A
- EPS Growth
- SWZ N/A
- PYXS N/A
- EPS
- SWZ N/A
- PYXS N/A
- Revenue
- SWZ N/A
- PYXS $16,146,000.00
- Revenue This Year
- SWZ N/A
- PYXS N/A
- Revenue Next Year
- SWZ N/A
- PYXS N/A
- P/E Ratio
- SWZ N/A
- PYXS N/A
- Revenue Growth
- SWZ N/A
- PYXS N/A
- 52 Week Low
- SWZ $7.12
- PYXS $1.39
- 52 Week High
- SWZ $8.57
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- SWZ 77.40
- PYXS 38.27
- Support Level
- SWZ $7.58
- PYXS $1.39
- Resistance Level
- SWZ $8.47
- PYXS $1.58
- Average True Range (ATR)
- SWZ 0.09
- PYXS 0.10
- MACD
- SWZ 0.12
- PYXS 0.03
- Stochastic Oscillator
- SWZ 99.23
- PYXS 32.56
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, and retail.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.